Cargando…

Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan

Detalles Bibliográficos
Autores principales: Shao, Yu-Hsuan Joni, Hong, Jian-Hua, Chen, Chun-Kai, Huang, Chao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449616/
https://www.ncbi.nlm.nih.gov/pubmed/36216968
http://dx.doi.org/10.1038/s41391-022-00596-5
_version_ 1785094994951929856
author Shao, Yu-Hsuan Joni
Hong, Jian-Hua
Chen, Chun-Kai
Huang, Chao-Yuan
author_facet Shao, Yu-Hsuan Joni
Hong, Jian-Hua
Chen, Chun-Kai
Huang, Chao-Yuan
author_sort Shao, Yu-Hsuan Joni
collection PubMed
description
format Online
Article
Text
id pubmed-10449616
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104496162023-08-26 Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan Shao, Yu-Hsuan Joni Hong, Jian-Hua Chen, Chun-Kai Huang, Chao-Yuan Prostate Cancer Prostatic Dis Correction Nature Publishing Group UK 2022-10-10 2023 /pmc/articles/PMC10449616/ /pubmed/36216968 http://dx.doi.org/10.1038/s41391-022-00596-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Shao, Yu-Hsuan Joni
Hong, Jian-Hua
Chen, Chun-Kai
Huang, Chao-Yuan
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title_full Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title_fullStr Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title_full_unstemmed Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title_short Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
title_sort correction to: cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in taiwan
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449616/
https://www.ncbi.nlm.nih.gov/pubmed/36216968
http://dx.doi.org/10.1038/s41391-022-00596-5
work_keys_str_mv AT shaoyuhsuanjoni correctiontocardiovascularriskofgonadotropinreleasinghormoneantagonistversusagonistinmenwithprostatecanceranobservationalstudyintaiwan
AT hongjianhua correctiontocardiovascularriskofgonadotropinreleasinghormoneantagonistversusagonistinmenwithprostatecanceranobservationalstudyintaiwan
AT chenchunkai correctiontocardiovascularriskofgonadotropinreleasinghormoneantagonistversusagonistinmenwithprostatecanceranobservationalstudyintaiwan
AT huangchaoyuan correctiontocardiovascularriskofgonadotropinreleasinghormoneantagonistversusagonistinmenwithprostatecanceranobservationalstudyintaiwan